Bezlotoxumab for crohn disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 4 Feb 2019: Trial registered, NCT03829475
  2. 1 Jan 2020: Trial started, NCT03829475

The trials

NCT03829475: ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI

State
Completed
Phase
Phase 2
People
61 taking part
Started
1 Jan 2020
Primary completion
3 Aug 2023
Arms
FMT + Bezlo
Results
Posted on the registry
  1. 4 Feb 2019: Trial registered
  2. 1 Jan 2020: Trial started
  3. 11 Dec 2024: Trial results posted
  4. 1 Jun 2025: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Zinplava.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.